REFERENCES
1. Zhu N, Zhang D, Wang W, Xingwang L, Bo Y, Jingdong S, Xiang Z, Baoying H, Weifeng S, Roujian L, Peihua N, Faxian Z. 2020. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 382:727-33. https://doi.org/10.1056/NEJMoa2001017.
2. Khan S, Siddique R, Shereen MA, Ali A, Liu J, Bai Q, Bashir N, Xue M. 2020. Emergence of a Novel Coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2: Biology and Therapeutic Options. J Clin Microb 58: e00187-20. https://doi.org/10.1128/JCM.00187-20.
3. Chowkwanyun M, Reed AL. 6 May 2020. Racial health disparities and Covid-19 - Caution and Context. N Engl J Med. https://doi.org/10.1056/NEJMp2012910.
4. Wang Z, Tang K. 2020. Combating COVID-19: health equity matters. Nat Med 26:458. https://doi.org/10.1038/s41591-020-0823-6.
5. Dong E, Du H, Gardner L. 2020. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis 20:533-4. https://doi.org/10.1016/S1473-3099(20)30120-1.
6. Curtis N, Sparrow A, Ghebreyesus TA, Netea MG. 30 April 2020. Considering BCG vaccination to reduce the impact of COVID-19. Lancet. https://doi.org/10.1016/S0140-6736(20)31025-4.
7. Ozdemir C, Kucuksezer UC, Tamay ZU. 24 April 2020. Is BCG vaccination effecting the spread and severity of COVID‐19? Allergy. https://doi.org/10.1111/all.14344.
8. Miller A, Reandelar MJ, Fasciglione K, Roumenova V, Li Yan, Otazu GH. 28 March 2020. Correlation between universal BCG vaccination policy and reduced morbidity and mortality for COVID-19: an epidemiological study. medRxiv https://doi.org/10.1101/2020.03.24.20042937.
9. Gursel M, Gursel I. 6 April 2020. Is global BCG vaccination coverage relevant to the progression of SARS-CoV-2 pandemic? Med Hypotheses. https://doi.org/10.1016/j.mehy.2020.109707.
10. Redelman-Sidi G. 27 April 2020. Could BCG be used to protect against COVID-19? Nat Rev Urol. https://doi.org/10.1038/s41585-020-0325-9.
11. Dayal D, Gupta S. 19 April 2020. Connecting BCG Vaccination and COVID-19: Additional Data. medRxiv https://doi.org/10.1101/2020.04.07.20053272.
12. Moorlag SJCFM, Arts RJW, van Crevel R, Netea MG. 2019. Non-specific effects of BCG vaccine on viral infections. Clin Microbiol Infect 25:1473-8. https://doi.org/10.1016/j.cmi.2019.04.020.
13. O’Neill LAJ, Netea MG. 11 May 2020. BCG-induced trained immunity: can it offer protection against COVID-19? Nat Rev Immunol. https://doi.org/10.1038/s41577-020-y.
14. Zwerling A, Behr MA, Verma A, Brewer TF, Menzies D, Pai M. 2019. The BCG world atlas: a database of global BCG vaccination policies and practices. PLoS Med 8:e1001012. https://doi.org/10.1371/journal.pmed.1001012.
15. Papke LE, Wooldridge JM. 1996. Econometric methods for fractional response variables with an application to 401(k) plan participation rates. J Appl Econom 11:619-32. https://doi.org/10.1002/(SICI)1099-1255(199611)11:6<619::AID-JAE418>3.0.CO;2-1
16. Papke LE, Wooldridge JM. 2008. Panel data methods for fractional response variables with an application to test pass rates. J Econom 145:121-33. https://doi.org/10.1016/j.jeconom.2008.05.009.
17. Borjas GJ. 2020. Demographic determinants of testing incidence and Covid-19 infections in New York City neighborhoods. National Bureau of Economic Research Working Paper Series 26952. https://doi.org/10.3386/w26952.
18. Kissler SM, Tedijanto C, Goldstein E, Grad YH, Lipsitch M. 14 April 2020. Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period. Science. https://doi.org/10.1126/science.abb5793.
19. The Lancet. 4 April 2020. Redefining vulnerability in the era of COVID-19. Lancet 395. https://www.thelancet.com/action/showPdf?pii=S0140-6736%2820%2930757-1.